Clinical Therapeutics

Editorial comment
pp. 1031-1032(2)
Author: Walson P.D.

Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction
pp. 1033-1048(16)
Author: Goldenberg M.M.

Levofloxacin: a therapeutic review
pp. 1049-1070(22)
Authors: Wimer S.M.; Schoonover L.; Garrison M.W.

Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection
pp. 1071-1092(22)
Authors: Pollard R.B.; Robinson P.; Dransfield K.

Use of midazolam in the treatment of refractory status epilepticus
pp. 1093-1105(13)
Authors: Hanley D.F.; Kross J.F.

Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker
pp. 1106-1114(9)
Authors: Pool J.; Oparil S.; Hedner T.; Glazer R.; Oddou-Stock P.; Hester A.

Efficacy and tolerability of cefprozil versus amoxicillin/clavulanate for the treatment of adults with severe sinusitis
pp. 1115-1129(15)
Authors: Adelglass J.; Bundy J.M.; Woods R.

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease
pp. 1130-1148(19)
Authors: Di Lorenzo G.; Morici G.; Drago A.; Pellitteri M.E.; Mansueto P.; Melluso M.; Norrito F.; Squassante L.; Fasolo A.; SLMT02 Italian Study Group

Effect of maalox on the oral absorption of sparfloxacin
pp. 1149-1158(10)
Authors: Johnson R.D.; Dorr M.B.; Talbot G.H.; Caille G.

Amlodipine, felodipine, and isradipine in the treatment of chinese patients with mild-to-moderate hypertension
pp. 1159-1169(11)
Authors: Cheung B.M.Y.; Lau C.-P.; Wu B.-Z.

Efficacy and tolerability of 0.5timolol maleate ophthalmic gel-forming solution QD compared with 0.5 2.510321e-311vobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension
pp. 1170-1178(9)
Authors: Walters T.R.; Maloney S.; Slater D.; Liss C.; Wilson H.; Hartenbaum D.

In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance
pp. 1179-1190(12)
Authors: Thornsberry C.; Ogilvie P.T.; Preston Holley H.; Sahm D.F.

Pharmaceutical economics & health policy - Editorial comment
pp. 1192-1193(2)
Author: Sclar D.A.

Emerging standardization in pharmacoeconomics
pp. 1194-1202(9)
Authors: Mullins C.D.; Ogilvie S.

Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine
pp. 1203-1217(15)
Authors: Procyshyn R.M.; Zerjav S.

Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis
pp. 1218-1235(18)
Authors: Simon L.S.; Zhao S.Z.; Arguelles L.M.; Lefkowith J.B.; Dedhiya S.D.; Fort J.G.; Johnson K.E.

Pharmaceuticals and medicare managed care: pharmacoeconomic considerations
pp. 1238-1240(3)
Authors: Cox E.R.; Coons S.J.

Medicare managed care: past, present, and future
pp. 1241-1249(9)
Author: Cooper B.

Medicare managed care: budgetary and tax implications
pp. 1250-1262(13)
Author: Vogel R.J.

Medicare managed care: consumers' perspectives
pp. 1263-1276(14)
Author: Wilson J.

Prescription drug formularies in managed care: concerns for the elderly population
pp. 1277-1291(15)
Author: Gross D.J.

Medicare managed care: policy concerns
pp. 1292-1300(9)
Author: Williams K.

Author index to volume 20
pp. 1301-1304(4)

Subject index to volume 20
pp. 1305-1310(6)